微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 66.36% | -13.15% | -2.59% | 33/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 68.12% | -2.31% | -1.63% | 33/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 69.25% | -0.4% | -3.08% | 33/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 71.46% | 0.12% | -6.48% | 24/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 76.4% | 0.31% | 9.56% | 17/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 69.74% | 0.02% | 0.3% | 26/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 69.53% | -0.02% | -2.59% | 27/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 71.37% | 0.41% | -6.3% | 22/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 76.17% | 9.81% | 9.24% | 14/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 69.73% | 0.63% | 0.26% | 27/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 69.54% | -1.04% | -2.17% | 29/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 71.08% | 2.74% | 2.48% | 25/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 69.36% | 2% | 0.11% | 31/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 69.29% | 2.87% | -1.41% | 38/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 70.28% | 2% | 1.57% | 30/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 69.19% | 7.88% | 2.73% | 42/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2020-12-31 | 67.35% | -1.8% | 5.02% | 47/131 | 59.59% | 正海生物 | 91.59% | 行业排名> |
| 2020-06-30 | 64.13% | 2% | -6.49% | 50/131 | 59.94% | 正海生物 | 92.23% | 行业排名> |
| 2019-12-31 | 68.59% | 8.68% | 8.68% | 37/131 | 56.37% | 正海生物 | 92.69% | 行业排名> |
| 2018-12-31 | 63.11% | 2.62% | 2.62% | 49/131 | 55.53% | 正海生物 | 92.61% | 行业排名> |
| 2017-12-31 | 61.5% | 2% | 2% | 45/131 | 55.34% | 正海生物 | 94.38% | 行业排名> |